IN-DATE
UL2-C: Neotract UroLift 2 Implant Cartridge
Sign in to add this product to your favorites!
| Price: | $1,049.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 5 eaches |
| Expiration: | 04-2027 |
Related Items
Additional Details
Neotract UroLift 2 Implant Cartridge
Item # UL2-C
For use with UroLift 2 Handle REF UL2-CHK
AccessGUDID Info
- FDA Product Code: PEW
- FDA Product Code Name: Implantable transprostatic tissue retractor system
- GMDN Term Code: 58882
- GMDN Term Name: Prostatic retraction implant
- GMDN Term Description: A sterile implantable device intended to increase prostatic urethral patency, and thereby relieve lower urinary tract symptoms (LUTS) due to benign prostatic hypertrophy (BPH), by physically compressing the prostate gland by retraction. The implant is in the form of a two orthogonal tags (e.g., metal) held together by a suture (e.g., monofilament), and is introduced so that one tag is outside the prostatic capsule and the other is in the urethra, with the suture providing retraction. It is not intended to be explanted. The device is implanted using a dedicated, single-use, hand-held, pistol-like delivery device through the sheath of a rigid endoscope.
Manufacturer
Neotract, a Teleflex Company, is a medical device company specializing in minimally invasive solutions for the treatment of benign prostatic hyperplasia (BPH). Their flagship product, the UroLift System, is a minimally invasive procedure designed to relieve the symptoms of BPH by lifting and holding the enlarged prostate tissue out of the way of the urethra. The UroLift System is designed to be performed under local anesthesia and does not require cutting, heating, or removal of prostate tissue. Neotract's focus is on providing effective, low-risk treatments that offer patients a faster recovery and fewer side effects compared to traditional surgical options.
